Morse J H, Witte L D, Goodman D S
J Exp Med. 1977 Dec 1;146(6):1791-803. doi: 10.1084/jem.146.6.1791.
Lipoproteins, isolated by sequential flotation at densities 1.006, 1.019, 1.063, and 1.21, were examined for their ability to inhibit human lymphocytes stimulated by allogeneic cells and by lectins (phytohemagglutinin-P and concanavalin A). All the classes of normal plasma lipoproteins inhibited lymphoproliferation when peripheral blood lymphocytes were cultured in autologous, heterologous, or lipoprotein-deficient plasma (d greater than 1.21). The rank order of inhibitory potency was intermediate density lipoprotein (IDL) greater than very low density lipoproteins (VLDL) greater than low density lipoproteins (LDL) greater than high density lipoproteins (HDL), regardless of the mode of stimulation. The concentrations of IDL, VLDL, and LDL required for complete inhibition of stimulated lymphoproliferation were considerably below the levels of each of these lipoproteins normally found in human plasma. In addition, the concentration of HDL required for 50-90% inhibition was in the range of HDL levels normally found in human plasma. Moreover, at relatively higher concentrations, lipoproteins suppressed the incorporation of [3H]thymidine into DNA below the levels seen with reseting, unstimulated lymphocytes. The results suggest that circulating lymphocytes may normally be highly suppressed by the combined effects of all the endogenous lipoproteins and that the lipoproteins may play important roles in vivo in modulating lymphocyte functions and responses.
通过在密度为1.006、1.019、1.063和1.21下进行连续浮选分离得到的脂蛋白,被检测其抑制同种异体细胞和凝集素(植物血凝素-P和刀豆球蛋白A)刺激的人淋巴细胞的能力。当外周血淋巴细胞在自体、异体或脂蛋白缺乏的血浆(密度大于1.21)中培养时,所有类型的正常血浆脂蛋白均抑制淋巴细胞增殖。无论刺激方式如何,抑制效力的顺序为中间密度脂蛋白(IDL)大于极低密度脂蛋白(VLDL)大于低密度脂蛋白(LDL)大于高密度脂蛋白(HDL)。完全抑制刺激的淋巴细胞增殖所需的IDL、VLDL和LDL浓度远低于正常人血浆中这些脂蛋白的水平。此外,50%-90%抑制所需的HDL浓度在正常人血浆中HDL水平范围内。而且,在相对较高浓度下,脂蛋白将[3H]胸腺嘧啶核苷掺入DNA的量抑制到低于静止、未刺激淋巴细胞的水平。结果表明,循环淋巴细胞可能通常受到所有内源性脂蛋白联合作用的高度抑制,并且脂蛋白可能在体内调节淋巴细胞功能和反应中发挥重要作用。